Literature DB >> 26606675

Analysis of Morbidity and Mortality Outcomes in Postoperative Clostridium difficile Infection in the Veterans Health Administration.

Xinli Li1, Mark Wilson2, William Nylander1, Tracy Smith1, Marilyn Lynn1, William Gunnar3.   

Abstract

IMPORTANCE: This study analyzes and reports Clostridium difficile infection (CDI) rates, risk factors, and associations with postoperative outcomes in the Veterans Health Administration (VHA).
OBJECTIVE: To report 30-day postoperative CDI rates and outcomes and identify associated risks by surgical procedures and preoperative patient demographics in a large integrated health care system. DESIGN, SETTING, AND PARTICIPANTS: In a retrospective observational study conducted from September 2014 to April 2015, the Veterans Affairs Surgical Quality Improvement Program database and the Decision Support System pharmacy database were linked to analyze the association of postoperative CDI with patients' demographics, preoperative comorbidities, operative characteristics, and preoperative medications. The Veterans Affairs Surgical Quality Improvement Program assessments from October 1, 2009, to September 30, 2013, were investigated. The study was conducted at 134 VHA surgery programs, and the study population represents 12 surgical specialties: general, gynecological, neurosurgical, oral, orthopedics, otolaryngologic, plastic, podiatric, thoracic, transplant, urologic, and peripheral vascular. MAIN OUTCOMES AND MEASURES: Thirty-day postoperative CDI rates, risk factors of CDI, and association of CDI with postoperative morbidity and mortality.
RESULTS: Among 468,386 surgical procedures, the postoperative CDI rate was 0.4% per year and varied by the VHA Surgery Program (0.0% to 1.4%) and surgical specialty (0.0% to 2.4%). Thirty-day CDI rates were higher in emergency procedures, procedures with greater complexity and higher relative value units, and those with a contaminated/infected wound classification. Patients with postoperative CDI were significantly older, more frequently hospitalized after surgery (59.9% vs 15.4%), had longer preoperative hospital stays (9.1 days vs 1.9 days), and had received 3 or more classes of antibiotics (1.5% vs 0.3% for a single antibiotic class) (all P < .001). Patients with CDI had higher rates of other postoperative morbidity (86.0% vs 7.1%), 30-day mortality (5.3% vs 1.0%), and longer postoperative hospital stays (17.9 days vs 3.6 days). Independent risk factors for CDI included commonly identified patient factors (albumin, functional class, and weight loss), procedural characteristics (complexity, relative value units, emergency, and wound classification), surgical program complexity, the number of preoperative antibiotic classes, and length of preoperative hospital stay. CONCLUSIONS AND RELEVANCE: The number and class of antibiotics administered after surgery, preoperative length of stay, procedural characteristics, surgical program complexity, and patient comorbidities are associated with postoperative CDI in the VHA.

Entities:  

Mesh:

Year:  2016        PMID: 26606675     DOI: 10.1001/jamasurg.2015.4263

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  7 in total

Review 1.  Hospital Infection Control: Clostridioides difficile.

Authors:  Nicholas A Turner; Deverick J Anderson
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

2.  Effect of Inclusion of Oral Antibiotics with Mechanical Bowel Preparation on the Risk of Clostridium Difficile Infection After Colectomy.

Authors:  Ahmed M Al-Mazrou; Laura Z Hyde; Kunal Suradkar; Ravi P Kiran
Journal:  J Gastrointest Surg       Date:  2018-07-02       Impact factor: 3.452

3.  Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case-control study.

Authors:  Vesna Šuljagić; Ivan Miljković; Srđan Starčević; Nenad Stepić; Zoran Kostić; Dragutin Jovanović; Jelena Brusić-Renaud; Biljana Mijović; Sandra Šipetić-Grujičić
Journal:  Antimicrob Resist Infect Control       Date:  2017-03-27       Impact factor: 4.887

4.  Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis.

Authors:  Alexandre R Marra; Eli N Perencevich; Richard E Nelson; Matthew Samore; Karim Khader; Hsiu-Yin Chiang; Margaret L Chorazy; Loreen A Herwaldt; Daniel J Diekema; Michelle F Kuxhausen; Amy Blevins; Melissa A Ward; Jennifer S McDanel; Rajeshwari Nair; Erin Balkenende; Marin L Schweizer
Journal:  JAMA Netw Open       Date:  2020-01-03

5.  A case report of successful management of fulminant Clostridium difficile colitis post-ileostomy reversal with administration of vancomycin through a transverse colostomy.

Authors:  Keiji Matsuda; Yojiro Hashiguchi; Mitsuo Tsukamoto; Kohei Ohno; Yuka Okada; Takahiro Yagi; Yoshihisa Fukushima; Atsushi Horiuchi; Ryu Shimada; Tsuyoshi Ozawa; Tamuro Hayama; Takeshi Tsuchiya; Junko Tamura; Hisae Iinuma; Keijiro Nozawa; Yuko Sasajima; Fukuo Kondo
Journal:  Surg Case Rep       Date:  2019-11-21

6.  Incidence, risk factors, and outcome of Clostridioides difficile infection following urological surgeries.

Authors:  Kevin A Nguyen; Danny Q Le; Yvonne T Bui; Sonali D Advani; Joseph Renzulli; Patrick A Kenney; Michael S Leapman
Journal:  World J Urol       Date:  2021-01-20       Impact factor: 4.226

7.  Clinical impact of a Clostridioides (Clostridium) difficile bedside infectious disease stewardship intervention.

Authors:  María Olmedo; Maricela Valerio; Elena Reigadas; Mercedes Marín; Luis Alcalá; Patricia Muñoz; Emilio Bouza
Journal:  JAC Antimicrob Resist       Date:  2020-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.